Source Pravda.Ru

Genetic Characteristics May be Key to Deciding Right Lung Cancer Treatments - Comments

Diagnostic tests that look for specific genetic or molecular characteristics may be the key to helping doctors decide which lung cancer treatments work best for patients, two studies released on Wednesday suggest.In one, researchers found AstraZeneca's ( AZN.L ) lung cancer pill Iressa, or gefitinib, worked far better than chemotherapy in people from East Asia whose tumors had specific mutations in genes for the epidermal growth factor receptor or EGFR

Show more